Assessment of External Beam Radiation Technology for Dose Escalation and Normal Tissue Protection in the Treatment of Prostate Cancer

Received 11 April 2007; received in revised form 14 September 2007; accepted 14 September 2007.

Refers to article:

Technology Assessment: Vigilance Required
W. Robert Lee
International Journal of Radiation Oncology * Biology * Physics
1 March 2008 (Vol. 70, Issue 3, Pages 652-653)
Full Text | Full-Text PDF (65 KB)

Prostate cancer, Dose escalation, IMRT, Biochemical failure, Normal tissue toxicity

No abstract is available. To read the body of this article, please view the Full Text online.

∗ Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA

† Division of Radiation Oncology, H. Lee Moffit Cancer Center, Tampa, FL

‡ Department of Radiation Oncology, UCSF Comprehensive Cancer Center, San Francisco, CA

§ California Endocurietherapy Cancer Center (CET), Oakland, CA

‖ Santa Monica Cancer Treatment Center, Santa Monica, CA

¶ Department of Radiation Oncology, South Nassau Communities Hospital, Oceanside, NY

∗∗ 21st Century Oncology, Moorestown, NJ

Reprint requests to: Andre Konski, M.D., M.B.A., M.A., Department of Radiation Oncology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111. Tel: (215) 728-2940; Fax: (215) 214-1629

Supported by departmental Varian research grant (A.P.); Departmental Siemens research grant (L.J.V.); ASTRO IMRT/3D-CRT Practicum faculty (R.A.P.); honoraria: Siemens (M.R.), ASTRO (M.R., P.E.W.), Nomos (M.L.S.), Glaxo Smith Kline (P.E.W.); Oncura and Theragenics meeting grant (L.P.).

PII: S0360-3016(07)04261-7

doi:10.1016/j.ijrobp.2007.09.034

8 of 60